Science Publications

Sign Up
Sign In
Submit
World Journal of Cancer and Oncology Research
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. World Journal of Cancer and Oncology Research
  4. Archive
  5. Volume 2, Issue 1, 2023
  6. Article
Review Article Open Access November 02, 2023

Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain

Manas Gorani 1,*
1
New Jersey, United States
Publihed in: World Journal of Cancer and Oncology Research (Volume 2, Issue 1, 2023)
Page(s): 54-59
DOI: 10.31586/ujpp.2023.1193
Received
August 06, 2023
Revised
September 11, 2023
Accepted
October 28, 2023
Published
November 02, 2023
Keywords
Active Pharmaceutical Ingredients; Supply Chain; Covid-19; Drug Shortage; Production; Pharmaceutical Regulations; Global Harmonization
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2023. Published by Scientific Publications
Article metrics
Views
375
Downloads
187

Cite This Article

APA Style
Gorani, M. (2023). Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain. World Journal of Cancer and Oncology Research, 2(1), 54-59. https://doi.org/10.31586/ujpp.2023.1193
ACS Style
Gorani, M. Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain. World Journal of Cancer and Oncology Research 2023 2(1), 54-59. https://doi.org/10.31586/ujpp.2023.1193
Chicago/Turabian Style
Gorani, Manas. 2023. "Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain". World Journal of Cancer and Oncology Research 2, no. 1: 54-59. https://doi.org/10.31586/ujpp.2023.1193
AMA Style
Gorani M. Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain. World Journal of Cancer and Oncology Research. 2023; 2(1):54-59. https://doi.org/10.31586/ujpp.2023.1193 
@Article{wjcor1193,
AUTHOR = {Gorani, Manas},
TITLE = {Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain},
JOURNAL = {World Journal of Cancer and Oncology Research},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {54-59},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/1193},
ISSN = {2836-3981},
DOI = {10.31586/ujpp.2023.1193},
ABSTRACT = {The pharmaceutical industry relies extensively on Active Pharmaceutical Ingredients (APIs) as essential components in the production of drugs. The supply chain supporting these APIs is complex, encompassing multiple stages from raw material sourcing to distribution to pharmaceutical manufacturers worldwide. This manuscript explores the intricate challenges encountered within the pharmaceutical API supply chain, focusing on regulatory compliance, quality control, supply chain disruptions, and global dependencies. Regulatory compliance poses a significant hurdle, with varying standards across regions necessitating meticulous adherence to ensure market access and product safety. Quality control and assurance are paramount to maintaining consistency and purity in APIs, yet they present ongoing challenges such as batch variability and contamination risks. Supply chain disruptions, ranging from natural disasters to geopolitical tensions, highlight vulnerabilities in global sourcing strategies, underscoring the need for resilient supply chain management practices. Global dependencies on a limited number of suppliers or regions expose the industry to supply shortages and pricing pressures, exacerbated by geopolitical events and trade policies. These dependencies necessitate strategic diversification and risk mitigation efforts to ensure continuity in API availability and affordability. By addressing these challenges collaboratively, stakeholders can enhance the resilience and reliability of the pharmaceutical API supply chain, thereby ensuring uninterrupted access to essential medications and improving global healthcare outcomes.},
}
%0 Journal Article
%A Gorani, Manas
%D 2023
%J World Journal of Cancer and Oncology Research

%@ 2836-3981
%V 2
%N 1
%P 54-59

%T Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain
%M doi:10.31586/ujpp.2023.1193
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/1193

TY  - JOUR
AU  - Gorani, Manas
TI  - Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain
T2  - World Journal of Cancer and Oncology Research
PY  - 2023
VL  - 2
IS  - 1
SN  - 2836-3981
SP  - 54
EP  - 59
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/1193
AB  - The pharmaceutical industry relies extensively on Active Pharmaceutical Ingredients (APIs) as essential components in the production of drugs. The supply chain supporting these APIs is complex, encompassing multiple stages from raw material sourcing to distribution to pharmaceutical manufacturers worldwide. This manuscript explores the intricate challenges encountered within the pharmaceutical API supply chain, focusing on regulatory compliance, quality control, supply chain disruptions, and global dependencies. Regulatory compliance poses a significant hurdle, with varying standards across regions necessitating meticulous adherence to ensure market access and product safety. Quality control and assurance are paramount to maintaining consistency and purity in APIs, yet they present ongoing challenges such as batch variability and contamination risks. Supply chain disruptions, ranging from natural disasters to geopolitical tensions, highlight vulnerabilities in global sourcing strategies, underscoring the need for resilient supply chain management practices. Global dependencies on a limited number of suppliers or regions expose the industry to supply shortages and pricing pressures, exacerbated by geopolitical events and trade policies. These dependencies necessitate strategic diversification and risk mitigation efforts to ensure continuity in API availability and affordability. By addressing these challenges collaboratively, stakeholders can enhance the resilience and reliability of the pharmaceutical API supply chain, thereby ensuring uninterrupted access to essential medications and improving global healthcare outcomes.
DO  - Revealing Complexity: Confronting Challenges in the Pharmaceutical API Supply Chain
TI  - 10.31586/ujpp.2023.1193
ER  -